Drug-Receptor Interaction

Slides:



Advertisements
Similar presentations
Introduction to Pharmacology
Advertisements

LAKSHMAN KARALLIEDDE OCTOBER 2011
DRUG-RECEPTOR INTERACTIONS
Bruce Wainman, PhD. Drugs and Marketing Drugs are often marketed as the most potent, the most efficacious, the most effective and the best tolerated The.
QUANTITATIVE ASPECTS OF DRUG ACTIONS DR. SHABANA ALI.
QUANTITATIVE ASPECTS OF DRUG ACTION
QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.
Chapter 5 Pharmacodynamics 1.
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
Dose-Response Relationships Lesson 6. Dose & Drug Effects n Pharmacodynamics l what the drug does to the body n Effects of drug depends on dose n In general...
Pharmacology Introduction
CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology Dr. Robert L. Patrick Department of Neuroscience Brown University Biomed.
Drug-Receptor Interactions Pharmacodynamics
Principles of Pharmacology: Pharmacodynamics

Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Adverse Reactions.
Pharmacodynamics Pharmacodynamics Department of pharmacology Yang Fangju( 杨芳矩)
© 2012 The McGraw-Hill Companies, Inc. All rights reserved. 1 Pharmacology: An Introduction CHAPTER.
Principles of Pharmacology: Pharmacodynamics
 Receptors are mostly membrane-bound proteins that selectively bind small molecules called ligands which results in physiological response.  They are.
 all drugs not in gaseous state need to use fluid routes of excretion ◦ fluid routes include -sweat, tears, saliva, mucous, urine, bile, human milk ◦
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
HuBio 543 September 6, 2007 Frank F. Vincenzi
BIOPHARMACEUTICS.
Year One Pharmacodynamics
Pharmacodynamics Ed Bilsky, Ph.D. Department of Pharmacology University of New England.
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
At the end of this lecture, the students will be able to: 1.Define receptors 2.Define agonists 3.List types of agonists 4. Define antagonists 5. List.
FOOD AND NUTRITIONAL TOXICOLOGY
Drug dosage. Dose-response relationship Depends on multiple factors A drug usually has one desired effect that causes a change in a target organ or structure.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
IV-BSCT Department of Physical Sciences Philippine Normal University.
415 PHT Plasma Level – Time Curve
Clinical Pharmacokinetics. Time course Duration Onset Absorptive phase Elimination phase.
Biological Evaluation Lecture - 3 Principles and Importance of BA’s Joseph O. Oweta B. Pharm (MUST)
Biological Evaluation Lecture - 4 Principles and Importance of BA’s Joseph O. Oweta B. Pharm (MUST)
Pharmacodynamics. Pharmacodynamics  The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects.
DRUG RECEPTORS AND PHARMACODYNAMICS
QUANTITATIVE ASPECTS OF DRUG ACTION
Section 1, Lecture 8 Receptor Classification according to: -which drugs they interact with (  -adrenergic –binds norepinphine with high affinity.
IN THE NAME OF GOD.
Pharmacodynamics What the drug does to the body?
To record DRC of Acetylcholine using rat ileum
MULTIPLE DOSAGE REGIMEN
QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
Drug Response Relationships
Pharmacodynamics 3.
Dissolution testing and in vitro in vivo correlation of conventional and SR preparations Formulation development and optimization is an ongoing process.
MBBS-BDS LECTURE NOTES
Brief Review of Dr. Swanson’s and Dr. Prakriya’s material
5 Pharmacodynamics.
Dose-response curves.
Clinical Pharmacokinetics
INTRODUCTION to Pharmacology
Pharmacodynamics 2.
Pharmacology UG-Course
Therapeutic Drug Monitoring chapter 1 part 1
Pharmacodynamic Dr. Hashem Mansour.
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Efficacy, Potency and Safety of Drugs
Drug ½ life time it takes plasma concentration or amount of drug in body to be reduced by 50% Provides a good indication of the time necessary to reach.
Introduction to Pharmacogenetics
Drug-Receptor Interaction
Drug-Receptor Interactions and Pharmacodynamics (cont.)
Drug-Receptor Interactions
Relative potency of Drugs
Drug- Receptor Interaction
Full agonists The “agonists” referred to so far are FULL AGONISTS
Presentation transcript:

Drug-Receptor Interaction Course Coordinator Jamaluddin Shaikh, Ph.D. School of Pharmacy, University of Nizwa Lecture-3 September 20, 2011

Dose Response Relationship To understand drug–receptor interactions, it is necessary to quantify the relationship between the drug and the biological effect it produces Since the degree of effect produced by a drug is generally a function of the amount administered, we can express this relationship in terms of a dose–response curve Because we cannot always quantify the concentration of drug in the biophase in the intact individual, it is customary to correlate effect with dose administered

Dose Response Relationship When a graded dose–response relationship exists, the response to the drug is directly related to the number of receptors with which the drug effectively interacts The principles derived from dose–response curves are the same in animals and humans However, obtaining the data for complete dose–response curves in humans is generally difficult or dangerous

Quantal Relationship In addition to the responsiveness of a given patient, one may be interested in the relationship between dose and some specified quantum of response among all individuals taking that drug Such information is obtained by evaluating data obtained from a quantal dose–response curve Anticonvulsants can be suitably studied by use of quantal dose–response curves The construction of a quantal dose–response curve requires that data be obtained from many individuals

Quantal Dose-Response Curve: Effective Dose The quantal dose–response curve represents estimates of the frequency with which each dose elicits the desired response in the population This is done through the calculation of an ED50, the dose that would protect 50% of the animals

Quantal Dose-Response Curve: Lethal Dose Important characteristic of a drug’s activity is its toxic effect and, the ultimate toxic effect is death A curve can be constructed by plotting percent of animals killed by any drug against dose This can calculate by the LD50, the dose that would kill 50% of animals

Therapeutic Index The ratio LD50/ED50 As a general rule, a drug should have a high therapeutic index; however, some important therapeutic agents have low indices The therapeutic index is a rough measure of safety and represents only the starting point in determining whether a drug is safe enough for human use

Graded Response A single animal gives graded responses to graded doses; that is, as the dose is increased, the response increases With graded responses, one can obtain a complete dose–response curve in a single animal

Idealized dose–response curves of three agonists (a, b, c) that increase heart rate but differ in potency, maximum effect, or both. Broken lines indicate 50% of maximum response (horizontal) and individual ED50 values (vertical)

Potency and Intrinsic Activity Another drug characteristic that can be compared by use of ED50 values is potency From the previous curve, less of drug ‘a’ is needed to produce a given response ED50b/ED50a= 3/.3=10, i.e., ‘a’ is 10 times more potent than ‘b’ In contrast, drug c has less maximum effect than either drug a or drug b. Drug c is said to have a lower intrinsic activity than the other two

Equation from Drug-Receptor Interaction K1 D + R D-R K2 K3 Response Affinity is k1/k2, and efficacy is represented by k3 Affinity and efficacy represent kinetic constants that relate the drug, the receptor, and the response at the molecular level Affinity is the measure of the net molecular attraction between a drug and its receptor Efficacy is a measure of the efficiency of the drug–receptor complex in initiating the signal transduction process